A ALIMENTARY TRACT AND METABOLISM
|
|
B BLOOD AND BLOOD FORMING ORGANS
|
|
C CARDIOVASCULAR SYSTEM
|
|
D DERMATOLOGICALS
|
D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
|
D02 EMOLLIENTS AND PROTECTIVES
|
D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
|
D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
|
D05 ANTIPSORIATICS
|
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
|
D06A ANTIBIOTICS FOR TOPICAL USE
|
D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
|
D06BA Sulfonamides
|
D06BB Antivirals
|
D06BB01 Idoxuridine
|
D06BB02 Tromantadine [DG:DG00405]
|
D06BB03 Aciclovir [DG:DG00406]
|
D06BB04 Podophyllotoxin
|
D06BB05 Inosine [DG:DG00407]
|
D06BB06 Penciclovir [DG:DG00408]
|
D06BB07 Lysozyme [DG:DG00409]
|
D08152 Lysozyme (DCF)
D03332 Lysozyme hydrochloride (JP17) <JP>
|
D06BB08 Ibacitabine
|
D06BB09 Edoxudine
|
D06BB10 Imiquimod
|
D06BB11 Docosanol
|
D06BB12 Sinecatechins
|
D06BB53 Aciclovir, combinations
|
D06BX Other chemotherapeutics
|
D06C ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS
|
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
|
D08 ANTISEPTICS AND DISINFECTANTS
|
D09 MEDICATED DRESSINGS
|
D10 ANTI-ACNE PREPARATIONS
|
D11 OTHER DERMATOLOGICAL PREPARATIONS
|
|
G GENITO URINARY SYSTEM AND SEX HORMONES
|
|
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
|
J ANTIINFECTIVES FOR SYSTEMIC USE
|
J01 ANTIBACTERIALS FOR SYSTEMIC USE
|
J02 ANTIMYCOTICS FOR SYSTEMIC USE
|
J04 ANTIMYCOBACTERIALS
|
J05 ANTIVIRALS FOR SYSTEMIC USE
|
J05A DIRECT ACTING ANTIVIRALS
|
J05AA Thiosemicarbazones
|
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors [DG:DG02840]
|
J05AC Cyclic amines
|
J05AD Phosphonic acid derivatives
|
J05AE Protease inhibitors [DG:DG01647]
|
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
|
J05AG Non-nucleoside reverse transcriptase inhibitors [DG:DG01889]
|
J05AH Neuraminidase inhibitors [DG:DG02842]
|
J05AJ Integrase inhibitors [DG:DG03135]
|
J05AP Antivirals for treatment of HCV infections
|
J05AR Antivirals for treatment of HIV infections, combinations
|
J05AX Other antivirals
|
J05AX01 Moroxydine
|
J05AX02 Lysozyme [DG:DG00409]
|
D08152 Lysozyme (DCF)
D03332 Lysozyme hydrochloride (JP17) <JP>
|
J05AX05 Inosine pranobex
|
J05AX06 Pleconaril
|
J05AX07 Enfuvirtide
|
J05AX09 Maraviroc
|
J05AX10 Maribavir
|
J05AX13 Umifenovir
|
J05AX17 Enisamium iodide
|
J05AX18 Letermovir
|
J05AX19 Tilorone
|
J05AX21 Pentanedioic acid imidazolyl ethanamide
|
J05AX23 Ibalizumab
|
J05AX24 Tecovirimat [DG:03049]
|
J05AX25 Baloxavir marboxil
|
J05AX26 Amenamevir
|
J05AX27 Favipiravir
|
J05AX28 Bulevirtide [DG:DG03116]
|
J05AX29 Fostemsavir [DG:DG03096]
|
J06 IMMUNE SERA AND IMMUNOGLOBULINS
|
J07 VACCINES
|
|
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
|
M MUSCULO-SKELETAL SYSTEM
|
|
N NERVOUS SYSTEM
|
|
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
|
R RESPIRATORY SYSTEM
|
|
S SENSORY ORGANS
|
|
V VARIOUS
|